scholarly journals Prediction of Model for End-Stage Liver Disease Combined with Serum Alpha-Fetoprotein and Cholinesterase Levels on the Short-Term Prognosis in Patients with Acute-on-Chronic Hepatitis B Liver Failure

2018 ◽  
Vol 08 (02) ◽  
pp. 107-114
Author(s):  
涓 杨
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Liver Failure ◽  
Chronic Hepatitis B ◽  
Alpha Fetoprotein ◽  
Short Term ◽  
End Stage Liver Disease ◽  
Serum Alpha Fetoprotein ◽  
End Stage

Model for End‐Stage Liver Disease With Additional Criteria to Predict Short‐Term Mortality in Severe Flares of Chronic Hepatitis B

Hepatology ◽  
2020 ◽  
Vol 72 (3) ◽  
pp. 818-828 ◽  
Author(s):  
James Fung ◽  
Lung‐Yi Mak ◽  
Albert Chi‐Yan Chan ◽  
Kenneth Siu‐Ho Chok ◽  
Tiffany Cho‐Lam Wong ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Short Term ◽  
End Stage Liver Disease ◽  
Short Term Mortality ◽  
End Stage

scholarly journals Development and validation of the nomogram based on INR and eGFR for estimation of mortality in patients with acute-on-chronic hepatitis B liver failure

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Shengnan Li ◽  
Xiehua Zhang ◽  
Qian Li ◽  
Binyue Lv ◽  
Yefan Zhang ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Liver Failure ◽  
Chronic Hepatitis B ◽  
Calibration Curve ◽  
Validation Cohort ◽  
External Validation ◽  
Short Term ◽  
Short Term Mortality

Abstract Aims and objectives Acute-on-chronic hepatitis B liver failure (ACHBLF) is a critical clinical syndrome with a high short-term mortality evolved from chronic hepatitis B (CHB)-related liver disease. Prediction of mortality risk and early intervention can improve the prognosis of patients. This study aimed to develop and validate the nomogram for short-time mortality estimation in ACHBLF patients defined according to Asian Pacific Association for the Study of the Liver (APASL). Methods A study of 105 ACHBLF patients with 90-day follow up was performed to develop the nomogram. Patients were randomly assigned to derivation cohort (n = 75) and validation cohort (n = 35) according to 7:3. Concordance index (C-index), calibration curve and decision curve analysis (DCA) were used to evaluate the nomogram. We also compared the nomogram with APASL ACLF research consortium (AARC) score, model for end-stage liver disease (MELD) score, MELD with serum sodium (MELD-Na) score and albumin-bilirubin (ALBI) score. The nomogram was validated using an external cohort including 40 patients. Results The 28-day and 90-day mortality of 105 patients were respectively 49.52% and 55.24%. Albumin (ALB), international normalized ratio (INR) and estimated glomerular filtration rate (eGFR) were independent predictors for 28-day mortality; INR and eGFR were independent predictors for 90-day mortality. C-index of Nomogram-1 for 28-day mortality and Nomogram-2 for 90-day mortality were respectively 0.82 and 0.81. Calibration curve and Hosmer–Lemeshow test (Nomogram-1, 0.323; Nomogram-2, 0.231) showed optimal agreement between observed and predicted death. Areas under receiver operator characteristic curve(AUROC) of Nomogram-1(0.772) and Nomogram-2(0.771) were larger compared with AARC, MELD, MELD-Na and ALBI score. The results were well estimated in the external validation cohort. Conclusions This study highlighted the predictive value of eGFR, and the nomogram based on INR and eGFR could effectively estimate individualized risk for short-term mortality of ACHBLF patients defined according to APASL.

Evaluation of Model for End-Stage Liver Disease for Prediction of Mortality in Decompensated Chronic Hepatitis B

2006 ◽  
Vol 101 (7) ◽  
pp. 1516-1523 ◽  
Author(s):  
Henry L-Y Chan ◽  
Angel M-L Chim ◽  
Joseph T-F Lau ◽  
Alex Y Hui ◽  
Vincent W-S Wong ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Liver Disease ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
End Stage Liver Disease ◽  
Prediction Of Mortality ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document